White House to Reschedule Marijuana, Signaling Easing of Federal Drug Controls
The White House has told federal agencies to prepare for an imminent move to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act, aiming to ease federal restrictions and align it with some prescription drugs. The plan follows President Trump’s expressed frustration with the pace of deregulation, with a DEA hearing anticipated but the process remains fluid and undecided.